Starling Oncology STLN
NASDAQ STLN
$5.97 -0.12 (-1.97%)
At close: Sep 3, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Gains from Investment Securities (2020 - 2026)

Analysis

Starling Oncology (STLN) Gains from Investment Securities (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 90.36 Bn 89.35 Bn 15.19 Bn
2 Tenet Healthcare 22.02 Bn 19.85 Bn 4.45 Bn
3 Encompass Health 12.13 Bn 11.99 Bn 1.34 Bn
4 Davita 11.78 Bn 11.09 Bn 1.16 Bn
5 Universal Health Services 10.09 Bn 9.95 Bn 3.29 Bn
6 Ensign 9.97 Bn 9.65 Bn 306.24 Mn
7 Chemed 6.93 Bn 6.89 Bn 221.47 Mn
8 Pacs 6.81 Bn 6.64 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.32 Bn 4.16 Bn 192.10 Mn
10 Starling Oncology 609.95 Mn 568.85 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -6,000.00
Mar 31, 2026 -168,000.00
Dec 31, 2025 1,000.00
Sep 30, 2025 150,000.00
Jun 30, 2025 53,000.00
Mar 31, 2025 43,000.00
Dec 31, 2024 -47,000.00
Sep 30, 2024 -20,000.00
Jun 30, 2024 -552,000.00
Dec 31, 2023 -11,000.00
Sep 30, 2023 203,000.00
Jun 30, 2023 -118,000.00
Mar 31, 2023 -752,000.00
Dec 31, 2022 -5.39 Mn
Sep 30, 2022 -3.58 Mn
Jun 30, 2022 -10.80 Mn
Mar 31, 2022 -39.44 Mn
Dec 31, 2021 -24.89 Mn
Dec 31, 2020 -5.20 Mn
Sep 30, 2020 2.30 Mn